Applied BioCode Corporation

NT$27.00As of Sun 8 Nov 2026, 12:00 UTC
TWSE:6598Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (7.30%)
Div yield —
ROE (6.93%)
Medical Devices
Beta (5Y) 0.61
PE TTM —
TSR TTM 17.90%
Mkt cap NT$2.776B
ROIC (5.43%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$26
(2.18%)
284.97%
Hold 3|10|2|3|12
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.49
0.51
0.54
0.55
5.62%
12.14%
23.05%
22.87%
RevenueNT$M
123.2
122.7
123.4
124.4
(5.81%)
(6.53%)
(3.60%)
(0.38%)
Peers (US$83.85M)
Cap (US$)
PE
87.09M
15.27x
76.16M
23.43x
81.93M
17.01x
Capital
TTM
5Y
10Y
Leveragex
1.462
(0.365)
(0.346)
EBIT/Intx
3.919
0.173
0.160
Own earn%
(431.74)
109.83
123.08
Sh yield%
31.40
23.00
25.69
Owners
Insiders/Inst%
11.24
67.48
Short interest%
2.34
SBC / revenue%
3.89
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
0–8
$1 testx
0.0
Incr. ROIC%
6